New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy. The study was presented today at the American Association of Cancer Research (AACR) virtual annual meeting.
Yale researchers provide new insights into acquired resistance to cancer immunotherapy
source: Emily Henderson - News Medical